Biology

Caspase-6-cleaved tau in Alzheimer’s disease

Changes in Rhes distribution associated with tau accumulation and neuronal vulnerability

Investigating differences in selective neuronal vulnerability in typical and atypical AD

Mass spectrometry-based proteomics identifies progressive changes in tau PTMs over time

Beyond amyloid & tau: neuroinflammation, rhes & proteomics

Advances in methodology for structural biology of neurodegeneration

Detecting microglial activation in Alzheimer’s disease

The future of gene targeting in treating Parkinson’s disease

The potential of lecanemab for the treatment of early Alzheimer’s disease

The impact of sex on Alzheimer’s disease presentation in adults with Down syndrome

AD pathology isn’t always associated with memory loss

What underlies the manifestation differences seen in atypical AD?

Overlapping genes in neurodegenerative diseases highlighted by transcriptomic analysis

Bringing plasma biomarkers into clinical practice: what does the future hold?

Beyond Aβ and p-Tau: novel biomarkers under investigation for Alzheimer’s disease

Increasing eIF2a phosphorylation to boost protein quality control in neurodegenerative disease